Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

Janux Therapeutics, Inc. (JANX) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

Janux Therapeutics, Inc. (JANX), most recent 12 months reported: revenue $24M, net loss $102.59M, free cash flow -$41.92M. Latest balance sheet on file: liquid cash $970.91M. From SEC filings. Others in Pharmaceutical Preparations: TONIX PHARMACEUTICALS HOLDING CORP. · Jaguar Health, Inc. · Stoke Therapeutics, Inc. · ABEONA THERAPEUTICS INC. · PRELUDE THERAPEUTICS INC · CASI PHARMACEUTICALS, INC. · Sol-Gel Technologies Ltd. · SCYNEXIS, Inc.

Stock screener

Watchlist